Mississippi Medical Research, LLC Report issue

For profit Phase 2
Founded: Picayune MS United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

ceftazidime (fortaz) (1 trial)

ceftolozane (Zerbaxa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Pyelonephritis (Phase 2)

Urinary Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2